A Novel Molecule “Shati” Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference

This work was supported in part by a Grant-in-Aid for Scientific Research and Special Coordination Funds for Promoting Science and Technology, Target-Oriented Brain Science Research Program; a Grant-in-Aid for Scientific Research (B), Exploratory Research, and Young Scientists (A); the 21st Century Center of Excellence Program “Integrated Molecular Medicine for Neuronal and Neoplastic Disorders” from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a Grant-in-Aid for Health Science Research on Regulatory Science of Pharmaceuticals and Medical Devices, and Comprehensive Research on Aging and Health from the Ministry of Health, Labor, and Welfare of Japan; a Smoking Research Foundation Grant for Biomedical Research; a grant from the Brain Research Center from the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea; by the Japan Canada Joint Health Research Program; and by a grant from Takeda Science Foundation. We are grateful to Drs. Kenji Kadomatsu, Yoshifumi Takei, and Hanayo Kawai (Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan) for technical assistance, critical comments, and helpful discussions. We also thank Dr. Noboru Ogiso, Yasutaka Ohya, Yuuki Ushiro, and Kazumi Kawai (Division for Research of Laboratory Animals, Center for Research of Laboratory Animals and Medical Research Engineering, Nagoya University Graduate School of Medicine) and Nobuyoshi Hamada and Yoshiyuki Nakamura (Radioisotope Center Medical Branch, Nagoya University Graduate School of Medicine) for technical assistance.